AlphaMeld Corporation
Arpit Jain currently serves as Senior Director of Corporate Strategy and Chief of Staff at AlphaMeld Corporation since October 2024. Previously, Arpit held the same titles at InveniAI LLC from May 2023 to September 2024 and spent over a decade at E Z BIOXCEL SOLUTIONS PRIVATE LIMITED, where Arpit advanced from Analyst to Senior Director of Corporate Strategy between July 2007 and November 2022. Arpit's educational background includes studies at Amity University and Modern School.
This person is not in any offices
AlphaMeld Corporation
Headquartered in Guilford, CT, AlphaMeld® Corporation (a wholly owned subsidiary of InveniAI LLC) stands as a global frontrunner in the application of AI, machine learning, and generative AI tools, catalyzing innovation throughout drug discovery and development. With a mission to identify and expedite transformative therapies for diseases with unmet medical needs, the company utilizes its cutting-edge AlphaMeld platform to extract valuable insights from petabytes of diverse data sets, propelling the creation of groundbreaking drug programs. The company's pioneering approach is underscored by successful collaborations with industry leaders and drug spinouts, solidifying its position as a trailblazer in the realm of AI-driven drug discovery. About The AlphaMeld® Platform The AlphaMeld platform employs a comprehensive approach to generate testable hypotheses, considering factors such as the ideal mode of pharmacotherapy, disease severity, gene ontology, disease pathways, proteinopathies, standard of care, emerging innovation, and enabling technologies. This is done while factoring in medical, scientific, strategic, and commercial considerations.